Symptoms and signs | Number affected (%) | Median duration in days (range) | |
---|---|---|---|
Fever | 96/97 (99 %) | 23; (6–96) | |
Vomiting | 76/100 (76 %) | 13; (1–96) | |
Weight loss | 59/98 (60 %) | 15.5; (7–90) | |
Confusion | 15/100 (15 %) | 10.4; (2–30) | |
Unconsciousness | 27/100 (27 %) | 5.3; (1–16) | |
Headachea | 49/55 (89 %) | 21; (4–66) | |
Fits | 39/100 (39 %) | 8.5; (1–35) | |
Neck stiffness | 75/100 (75Â %) | Â | |
Hemiparesis/Hemiplegia | 20/98 (20Â %) | Â | |
Paraparesis/paraplegia | 6/98 (6Â %) | Â | |
Monoplegia | 4/98 (4Â %) | Â | |
Quadriplegia | 2/98 (2Â %) | Â | |
II nerve involvement | 3/98 (3Â %) | Â | |
III nerve palsy | 4/98 (4Â %) | Â | |
VI nerve palsy | 20/98 (20Â %) | Â | |
VII nerve palsy | 7/98 (7Â %) | Â | |
Anemia (Hb < 11 g/dL) | 46/99 (46 %) |  | |
HIV infection | 4/96 (4Â %) | Â | |
HBV infection | 5/96 (5Â %) | Â | |
MRC Grades >5Â years (33) | I: 16 (48Â %) | II: 11 (33Â %) | III: 6 (18Â %) |
Blantyre < 5 years (67) | 4–5: 43 (64 %) | 2–3: 12 (18 %) | 0–1: 12 (18 %) |
Deaths | 15/100 (15Â %) | Â | |
Sequelae | |||
 Severe | 6/81 (7 %) |  | |
 Intermediate | 21/81 (26 %) |  |